5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]-
|
|
|
- CAS-Nr.
- 74356-00-6
- Bezeichnung:
- 5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]-
- Englisch Name:
- Cefotetan disodium
- Synonyma:
- Cefotan in plastic container;Cefotetan and dextrose in duplex container;Cefotetan disodi;CEFOTETAN DISODIUM;Ondansetron Impurity 14;Cefotetan DisodiuM Sterile;Cefotetan Sodium (ICI156834;Cefotetan disodium USP/EP/BP;Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[4-(2-aMino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]aMino]-7-Methoxy-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-,sodiuM salt (1:2), (6R,7S)-
- CBNumber:
- CB82130367
- Summenformel:
- C17H18N7NaO8S4
- Molgewicht:
- 599.6
- MOL-Datei:
- 74356-00-6.mol
|
5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]- Eigenschaften
- Siedepunkt:
- 798℃
- RTECS-Nr.
- XI0330600
- storage temp.
- 2-8°C
- Löslichkeit
- Freely soluble in aqueous solution
- Aggregatzustand
- powder
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
| Kennzeichnung gefährlicher |
Xn |
|
|
| R-Sätze: |
20/21/22-36/37/38 |
|
|
| S-Sätze: |
26-36 |
|
|
| WGK Germany |
3 |
|
|
| HS Code |
29419000 |
|
|
| Toxizität |
LD50 in male mice, rats (g/kg): 6.35, 8.48 i.v.; 8.12, 8.37 i.p.; >10 orally and s.c. both species (Imamura) |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H317 |
Kann allergische Hautreaktionen verursachen. |
Sensibilisierung der Haut |
Kategorie 1A |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P261, P272, P280, P302+P352,P333+P313, P321, P363, P501 |
| H334 |
Kann bei Einatmen Allergie, asthmaartige Symptome oder Atembeschwerden verursachen. |
Sensibilisierung der Atemwege |
Kategorie 1 |
Achtung |
![GHS hazard pictograms]() src="/GHS08.jpg" width="20" height="20" /> |
P261, P285, P304+P341, P342+P311,P501 |
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P284 |
Atemschutz tragen. |
| P304+P340 |
BEI EINATMEN: Die Person an die frische Luft bringen und für ungehinderte Atmung sorgen. |
|
5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]- Chemische Eigenschaften,Einsatz,Produktion Methoden
R-Sätze Betriebsanweisung:
R20/21/22:Gesundheitsschädlich beim Einatmen,Verschlucken und Berührung mit der Haut.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.
S-Sätze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Beschreibung
Cefotetan disodium is a β-lactamase resistant, second generation cephalosporin
with a serum half-life of about three hours, permitting twice-daily dosing.
Verwenden
Cefotetan Disodium is a related compound of Cefotetan (C242970), an antibiotic related to Cephalosporin that is used to treat bacterial infections.
Definition
ChEBI: The disodium salt of cefotetan.
Clinical Use
Cefotetan (Cefotan) is a third-generation cephalosporin thatis structurally similar to cefoxitin. Like cefoxitin, cefotetanis resistant to destruction by β-lactamases. It is also a competitiveinhibitor of many β-lactamases and causes transient inactivation of some of these enzymes. Cefotetan is reportedto synergize with β-lactamase–sensitive β-lactams but, unlikecefoxitin, does not appear to cause antagonism.
The antibacterial spectrum of cefotetan closely resemblesthat of cefoxitin. It is, however, generally more activeagainst S. aureus, and members of the Enterobacteriaceaefamily sensitive to both agents. It also exhibits excellentpotency against H. influenzae and N. gonorrhoeae, includingβ-lactamase–producing strains. Cefotetan is slightly lessactive than cefoxitin against B. fragilis and other anaerobes.Enterobacter spp. are generally resistant to cefotetan, andthe drug is without effect against Pseudomonas spp.Cefotetan has a relatively long half-life of about 3.5hours. It is administered on a twice-daily dosing schedule. Itis excreted largely unchanged in the urine. Aqueoussolutions for parenteral administration maintain potency for24 hours at 25°C. Refrigerated solutions are stable for 4 days.
Cefotetan contains the MTT group that has been associatedwith hypoprothrombinemia and alcohol intolerance.Another cephalosporin that lacks these properties should beselected for patients at risk for severe bleeding or alcoholism.
5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 92)Lieferanten
74356-00-6(5-Thia-1-azabicyclo[4.2.0]oct-2-en-2-carbonsure, 7-[[[4-(2-Amino-1-carboxy-2-oxoethyliden)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, Dinatriumsalz, [6R-(6α,7α)]-)Verwandte Suche:
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6R-(6alpha,7alpha))-
- CEFOTETAN DISODIUM
- Disodium (7R)-7-[[4-(carbamoyl-carboxylato-methylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[[4-(2-aMino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]aMino]-7-Methoxy-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-,sodiuM salt (1:2), (6R,7S)-
- Cefotetan disodi
- Cefotetan DisodiuM Sterile
- Cefotetan disodium USP/EP/BP
- Cefotetan Sodium (ICI156834
- Cefotan in plastic container
- Cefotetan and dextrose in duplex container
- Ondansetron Impurity 14
- 74356-00-6
